首页> 外文期刊>Journal of pain & palliative care pharmacotherapy >Oral Versus Topical Diclofenac Sodium in the Treatment of Osteoarthritis
【24h】

Oral Versus Topical Diclofenac Sodium in the Treatment of Osteoarthritis

机译:口腔与局部双氯芬酸钠治疗骨关节炎

获取原文
获取原文并翻译 | 示例
           

摘要

Osteoarthritis (OA) is one of the most common causes of joint pain in the United States and non-steroidal anti-inflammatories (NSAIDs), such as Diclofenac sodium, which is currently available in two main routes of administration; oral and topical distribution have been established as one of the standard treatments for OA. Generally, oral NSAIDs are well tolerated; however our narrative review suggests that the topical solution had a better tolerability property than oral Diclofenac sodium, especially due to side effects of gastrointestinal bleeding with the utilization of the oral format. In addition, the topical route may be considered a reasonable selection by clinicians for management of musculoskeletal pain in those patients with a history of potential risk and adverse side effects. Most studies reviewed comparing oral versus topical solution of Diclofenac sodium revealed comparable efficacy, with minimal side effects utilizing the topical route. The key point of this narrative review is to help clinicians that currently must decide between very inexpensive diclofenac oral presentations and expensive topical presentations especially in the elderly population and the pros and cons of such decision-making process.
机译:骨关节炎(OA)是美国和非甾体抗炎症(NSAIDs)的关节疼痛最常见的原因之一,如双氯芬酸钠,目前有两种主要行政途径;已经建立了口腔和局部分布作为OA的标准治疗之一。通常,口腔NSAID是耐受良好的;然而,我们的叙述审查表明,局部解决方案具有比口服双氯芬酸钠更好的耐受性性质,特别是由于胃肠道出血利用口腔形式的副作用。此外,局部途径可被临床医生视为合理的选择,用于在潜在风险历史和不良副作用的患者中管理肌肉骨骼疼痛。大多数研究评估了对比较的双氯芬酸钠潜水溶液的口腔相比揭示了可比功效,利用局部途径的最小副作用。这一叙事审查的关键点是帮助目前必须在非常便宜的双氯芬克口头演示和昂贵的局部演示之间提供临床医生,特别是在老年人的人口和这种决策过程中的利弊。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号